<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03974295</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00040515</org_study_id>
    <nct_id>NCT03974295</nct_id>
  </id_info>
  <brief_title>The Impact of Vaginal Intercourse on Pregnancy Rates After Frozen Embryo Transfer</brief_title>
  <official_title>The Impact of Vaginal Intercourse on Pregnancy Rates After Frozen Embryo Transfer; A Single Blinded Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate whether allowing unprotected vaginal intercourse 24 hours after
      frozen embryo transfer will result in higher ongoing clinical pregnancy rates in comparison
      to having participants abstain from unprotected vaginal intercourse until pregnancy test
      (10-14 days after frozen embryo transfer).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Given the overwhelming evidence suggesting beneficial effect of seminal plasma on embryo
      implantation, we sought to explore this benefits in in vitro fertilization treatments by
      limiting the study cohort to those having frozen embryo transfer with programmed hormone
      replacement for endometrial preparation and some form of parenteral progesterone
      supplementation. This design will enable us to overcome the concerns and limitations of all
      previous studies. In this study, patients will be randomized into two groups, group 1 will
      have their frozen embryo transfer followed by current standard of care (no unprotected
      vaginal intercourse until pregnancy test) and group 2 will have their frozen embryo transfer
      followed by unlimited unprotected vaginal intercourse starting 24 hours after transfer. The
      primary endpoint of the study will be ongoing clinical pregnancy

      rates in the two groups while secondary endpoints will include implantation, positive
      pregnancy, miscarriage and live birth rates. Overall, this study aims to investigate whether
      the elimination of current universal pelvic rest protocol in patients undergoing frozen
      embryo transfer will help optimize pregnancy outcomes.

      This study aims to evaluate whether allowing unprotected vaginal intercourse 24 hours after
      frozen embryo transfer will result in higher ongoing clinical pregnancy rates in comparison
      to having participants abstain from unprotected vaginal intercourse until pregnancy test
      (10-14 days after frozen embryo transfer).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>After informed consent signing and randomization using a computer generated randomization scheme, the Research Nurse will open a numbered, opaque, and sealed envelope, within which there will be a white sheet of paper labelled with the patient assigned group. The participant will be informed of their assigned group by the Research Nurse. Patients assigned to the study group will be handed a log to record the number of times the patient engages in unprotected vaginal intercourse. The fertility providers will be blinded to the patients assigned treatment group. Patients who do not consent to be part of the study will still undergo their planned frozen embryo transfer per protocol.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy rates</measure>
    <time_frame>up to 2 years</time_frame>
    <description>A serum quantitative pregnancy test will be performed 10-14 days following the frozen embryo transfer per clinic protocol. Positive pregnancy test is defined a serum quantitative beta hCG &gt; 5 mU/mL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rates</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Implantation rate will be defined as number of gestational sacs observed at echographic screening at 6 weeks of pregnancy divided by the number of embryos transferred.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Ongoing clinical pregnancy rate is defined as presence of a fetal heartbeat at 6-7 weeks of pregnancy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancy rate</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Biochemical pregnancy rate is defined as positive pregnancy test or elevated Î²-hCG level which does not result in implantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Miscarriage rate</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Miscarriage rate is defined as a pregnancy loss is the loss of a fetus that occurs before 20 weeks of gestation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Live birth rate is defined as number of deliveries that resulted in a live born neonate, expressed per 100 embryo transfers.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Infertility</condition>
  <condition>Pregnancy Related</condition>
  <condition>IVF</condition>
  <arm_group>
    <arm_group_label>Intercourse Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>unlimited unprotected vaginal intercourse starting 24 hours after the frozen embryo transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pelvic Rest Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>pelvic rest after frozen embryo transfer until positive pregnancy test</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Vaginal unprotected intercourse</intervention_name>
    <description>Patients will allowed to engage in vaginal unprotected intercourse as many times as desired after 24 hours of pelvic rest after a frozen embryo transfer.</description>
    <arm_group_label>Intercourse Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female fertility patients having frozen embryo transfer

          -  programmed hormone replacement (Oral Estrace, Vivelle dot (patch), intravenous
             Estradiol) with and without gonadotrophin releasing hormone analogue pretreatment and
             some form of parenteral progesterone supplementation (daily or every 3 days
             intramuscular Progesterone) for luteal support

        Exclusion Criteria:

          -  unable to provide informed consent

          -  not undergoing programmed hormone replacement for frozen embryo transfer (natural
             cycle frozen embryo transfer)

          -  undergoing fresh embryo transfer

          -  not able to engage in heterosexual intercourse (same sex couple, partner with severe
             sexual dysfunction)

          -  cannot undergo unprotected vaginal intercourse (infected with hepatitis B, C, or human
             immunodeficiency virus).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only patients undergoing embryo transfer will be candidates for the study.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Gaikwad S, Garrido N, Cobo A, Pellicer A, Remohi J. Bed rest after embryo transfer negatively affects in vitro fertilization: a randomized controlled clinical trial. Fertil Steril. 2013 Sep;100(3):729-35. doi: 10.1016/j.fertnstert.2013.05.011. Epub 2013 Jun 10.</citation>
    <PMID>23755954</PMID>
  </reference>
  <reference>
    <citation>Lambers MJ, Lambalk CB, Schats R, Hompes PG. Ultrasonographic evidence that bedrest after embryo transfer is useless. Gynecol Obstet Invest. 2009;68(2):122-6. doi: 10.1159/000226283. Epub 2009 Jul 3.</citation>
    <PMID>19590224</PMID>
  </reference>
  <reference>
    <citation>Su TJ, Chen YC, Hung YT, Yang YS. Comparative study of daily activities of pregnant and non-pregnant women after in vitro fertilization and embryo transfer. J Formos Med Assoc. 2001 Apr;100(4):262-8.</citation>
    <PMID>11393126</PMID>
  </reference>
  <reference>
    <citation>Li B, Zhou H, Li W. Bed rest after embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2011 Apr;155(2):125-8. doi: 10.1016/j.ejogrb.2010.12.003. Review.</citation>
    <PMID>21300426</PMID>
  </reference>
  <reference>
    <citation>Purcell KJ, Schembri M, Telles TL, Fujimoto VY, Cedars MI. Bed rest after embryo transfer: a randomized controlled trial. Fertil Steril. 2007 Jun;87(6):1322-6. Epub 2007 Mar 23.</citation>
    <PMID>17362946</PMID>
  </reference>
  <reference>
    <citation>Botta G, Grudzinskas G. Is a prolonged bed rest following embryo transfer useful? Hum Reprod. 1997 Nov;12(11):2489-92.</citation>
    <PMID>9436691</PMID>
  </reference>
  <reference>
    <citation>Sharif K, Afnan M, Lenton W, Khalaf Y, Ebbiary N, Bilalis D, Morgan C. Do patients need to remain in bed following embryo transfer? The Birmingham experience of 103 in-vitro fertilization cycles with no bed rest following embryo transfer. Hum Reprod. 1995 Jun;10(6):1427-9.</citation>
    <PMID>7593509</PMID>
  </reference>
  <reference>
    <citation>RezÃ¡bek K, KoryntovÃ¡ D, ZivnÃ½ J. [Does bedrest after embryo transfer cause a worse outcome in in vitro fertilization?]. Ceska Gynekol. 2001 May;66(3):175-8. Czech.</citation>
    <PMID>11464374</PMID>
  </reference>
  <reference>
    <citation>Aoki Y, Kumakiri J, Itakura A, Kikuchi I, Takahashi N, Satoru T. Should sexual intercourse be avoided during the embryo transfer cycle? Life-threatening ruptured heterotopic pregnancy after single thawed embryo transfer: case report and review of the literature. Clin Exp Obstet Gynecol. 2017;44(3):489-491. Review.</citation>
    <PMID>29949304</PMID>
  </reference>
  <reference>
    <citation>Schjenken JE, Robertson SA. Seminal Fluid Signalling in the Female Reproductive Tract: Implications for Reproductive Success and Offspring Health. Adv Exp Med Biol. 2015;868:127-58. doi: 10.1007/978-3-319-18881-2_6. Review.</citation>
    <PMID>26178848</PMID>
  </reference>
  <reference>
    <citation>Gutsche S, von Wolff M, Strowitzki T, Thaler CJ. Seminal plasma induces mRNA expression of IL-1beta, IL-6 and LIF in endometrial epithelial cells in vitro. Mol Hum Reprod. 2003 Dec;9(12):785-91.</citation>
    <PMID>14614040</PMID>
  </reference>
  <reference>
    <citation>Sharkey DJ, Macpherson AM, Tremellen KP, Mottershead DG, Gilchrist RB, Robertson SA. TGF-Î² mediates proinflammatory seminal fluid signaling in human cervical epithelial cells. J Immunol. 2012 Jul 15;189(2):1024-35. doi: 10.4049/jimmunol.1200005. Epub 2012 Jun 15.</citation>
    <PMID>22706080</PMID>
  </reference>
  <reference>
    <citation>Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod. 1997 Mar;12(3):569-74.</citation>
    <PMID>9130761</PMID>
  </reference>
  <reference>
    <citation>Lim KJ, Odukoya OA, Ajjan RA, Li TC, Weetman AP, Cooke ID. The role of T-helper cytokines in human reproduction. Fertil Steril. 2000 Jan;73(1):136-42.</citation>
    <PMID>10632428</PMID>
  </reference>
  <reference>
    <citation>von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod. 2000 Jul;6(7):627-34.</citation>
    <PMID>10871650</PMID>
  </reference>
  <reference>
    <citation>Tremellen KP, Valbuena D, Landeras J, Ballesteros A, Martinez J, Mendoza S, Norman RJ, Robertson SA, SimÃ³n C. The effect of intercourse on pregnancy rates during assisted human reproduction. Hum Reprod. 2000 Dec;15(12):2653-8.</citation>
    <PMID>11098040</PMID>
  </reference>
  <reference>
    <citation>Crawford G, Ray A, Gudi A, Shah A, Homburg R. The role of seminal plasma for improved outcomes during in vitro fertilization treatment: review of the literature and meta-analysis. Hum Reprod Update. 2015 Mar-Apr;21(2):275-84. doi: 10.1093/humupd/dmu052. Epub 2014 Oct 3. Review.</citation>
    <PMID>25281684</PMID>
  </reference>
  <reference>
    <citation>Nawroth F, von Wolff M. Seminal Plasma Activity to Improve Implantation in In Vitro Fertilization-How Can It Be Used in Daily Practice? Front Endocrinol (Lausanne). 2018 Apr 27;9:208. doi: 10.3389/fendo.2018.00208. eCollection 2018.</citation>
    <PMID>29755413</PMID>
  </reference>
  <reference>
    <citation>Steiner AZ, Pritchard DA, Young SL, Herring AH. Peri-implantation intercourse lowers fecundability. Fertil Steril. 2014 Jul;102(1):178-82. doi: 10.1016/j.fertnstert.2014.03.017. Epub 2014 Apr 18.</citation>
    <PMID>24746744</PMID>
  </reference>
  <reference>
    <citation>von Wolff M, RÃ¶sner S, Germeyer A, Jauckus J, Griesinger G, Strowitzki T. Intrauterine instillation of diluted seminal plasma at oocyte pick-up does not increase the IVF pregnancy rate: a double-blind, placebo controlled, randomized study. Hum Reprod. 2013 Dec;28(12):3247-52. doi: 10.1093/humrep/det351. Epub 2013 Sep 17.</citation>
    <PMID>24045780</PMID>
  </reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 20, 2019</study_first_submitted>
  <study_first_submitted_qc>June 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2019</study_first_posted>
  <last_update_submitted>June 3, 2019</last_update_submitted>
  <last_update_submitted_qc>June 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

